Last week saw the presentation of the Farma-Biotech Cooperation Program report, fostered by the pharma trade group Farmaindustria.
This report features the most important landmarks of this initiative during the period 2011 (when it was initiated) and 2014. Thus, it is worth highlighting that, during the 12 meetings celebrated within the framework of the Program, more than 93 stakeholders have participated, generating 86 projects of interest, said Farmaindustria.
The Farma-Biotech Cooperation Program was born in 2011 in the framework of the Spanish Technological Platform for Innovative Medicines with the aim of facilitating the necessary information and fostering potential cooperation agreements between pharmaceutical companies, Spanish small biotechnological enterprises and research centers.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze